Markus Haeberlein

Markus Haeberlein

Director/Board Member at XSPRAY PHARMA AB
57 year
Health Technology
Consumer Services

Profile

Markus Haeberlein is currently an Independent Director at Xspray Pharma AB since 2025 and Executive Vice President-Discovery Science at Parabilis Medicines, Inc. since 2024.
Former positions include Director & Head-Medicinal Chemistry at AstraZeneca LP, Senior Vice President-Research at Alkermes Plc, and Senior Vice President & Head-Research at Proteostasis Therapeutics, Inc. from 2012 to 2014.
Education includes graduate and doctorate degrees from the Royal Institute of Technology.

Markus Haeberlein active positions

CompaniesPositionStart
XSPRAY PHARMA AB Director/Board Member 2024-12-31
PARABILIS MEDICINES, INC. Corporate Officer/Principal 2024-02-29

Former positions of Markus Haeberlein

CompaniesPositionEnd
Director/Board Member -
ALKERMES PLC Chief Tech/Sci/R&D Officer -
PROTEOSTASIS THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
See the detail of Markus Haeberlein's experience

Training of Markus Haeberlein

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Markus Haeberlein